The Anti-Candida albicans Vaccine Composed of the Recombinant N Terminus of Als1p Reduces Fungal Burden and Improves Survival in Both Immunocompetent and Immunocompromised Mice

We have previously shown that intraperitoneal vaccination with the recombinant N terminus of Als1p (rAls1p-N) modestly improves survival during murine disseminated candidiasis. We now report marked efficacy with subcutaneous rAls1p-N vaccination. Efficacy is retained in neutropenic and corticosteroi...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Spellberg, Brad J., Ibrahim, Ashraf S., Avenissian, Valentina, Filler, Scott G., Myers, Carter L., Fu, Yue, Edwards, John E.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2005
נושאים:
Fungal and Parasitic Infections
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1231102/
https://ncbi.nlm.nih.gov/pubmed/16113347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.73.9.6191-6193.2005
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים